Profile of Nonprotein Thiols, Lipid Peroxidation and D-Aminolevulinate Dehydratase Activity in Mouse Kidney and Liver in Response To Acute Exposure To Mercuric Chloride and Sodium Selenite
Profile of Nonprotein Thiols, Lipid Peroxidation and D-Aminolevulinate Dehydratase Activity in Mouse Kidney and Liver in Response To Acute Exposure To Mercuric Chloride and Sodium Selenite
Profile of Nonprotein Thiols, Lipid Peroxidation and D-Aminolevulinate Dehydratase Activity in Mouse Kidney and Liver in Response To Acute Exposure To Mercuric Chloride and Sodium Selenite
www.elsevier.com/locate/toxicol
Profile of nonprotein thiols, lipid peroxidation and daminolevulinate dehydratase activity in mouse kidney and liver
in response to acute exposure to mercuric chloride and sodium
selenite
Marcelo Farina a,c,, Ricardo Brandao a, Fabiana S. de Lara a,
Letcia B. Pagliosa a, Felix A. Soares c, Diogo O. Souza c, Joao B.T. Rocha b
a
Curso de Farmacia, Centro de Ciencias da Saude, Universidade Regional Integrada do Alto Uruguai e Missoes, C
ampus de Erechim,
99700-000 Erechim, RS, Brazil
b
Departamento de Qumica, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS,
Brazil
c
Departamento de Bioqumica, ICBS, Instituto de Ciencias Basicas da Saude, Universidade Federal do Rio Grande do Sul, Rua Ramiro
Barcelos, 2600 Anexo, Bairro Santana, 90035-003 Porto Alegre, RS, Brazil
Received 9 May 2002; received in revised form 11 September 2002; accepted 15 September 2002
Abstract
The effects of mercury (Hg2) and selenite (Se4 ) on d-aminolevulinic acid dehydratase (d-ALA-D) activity, 2thiobarbituric acid reactive substances (TBARS) and nonprotein sulfhydryl content (NPSH) in mouse kidney and liver
were investigated. Male mice were given a single i.p. injection of Hg2 and/or Se4 (25 mmol/kg) and were killed at 6,
12, 24 and 48 h after treatment. Hg2 inhibited renal d-ALA-D at 6 and 12 h after treatment. Se4 abolished the
inhibitory effect of mercury on renal d-ALA-D at 12 h after treatment. Renal and hepatic NPSH content decreased
after Hg2 exposure and selenite inhibited, at least in part, the Hg-induced oxidation of renal and hepatic NPSH. Se4
and Hg2 , when injected alone, did not alter hepatic or renal TBARS levels; however, simultaneous exposure to these
compounds increased hepatic and renal TBARS levels at 12 and 48 h after treatment, respectively. Present results
suggest that selenium abolishes the interaction of Hg2 with sulfhydryl groups of protein and nonprotein sources.
# 2002 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Thiol groups; Lipid peroxidation; d-Aminolevulinate dehydratase; Selenium; Mercury; Interaction
1. Introduction
0300-483X/02/$ - see front matter # 2002 Elsevier Science Ireland Ltd. All rights reserved.
PII: S 0 3 0 0 - 4 8 3 X ( 0 2 ) 0 0 5 7 6 - 0
180
2. Methods
2.1. Compounds
Reduced glutathione, 5,5?-dithio-bis(2-nitrobenzoic acid) (DTNB), 5-aminolevulinic acid, brilliant
blue G, 2-thiobarbituric acid, acetic acid and p dimethylaminobenzaldehyde were obtained from
Sigma Chemical Co. (St. Louis, MO, USA).
Bovine serum albumin, mono- and dibasic potassium phosphate, acetic acid, ortho -phosphoric
acid, trichloroacetic acid, sodium chloride, sodium
selenide and mercuric chloride were obtained from
Merck (Darmstadt, Germany).
2.2. Animals and treatment
Adult male mice (Swiss albino) from our own
breeding colony were maintained under controlled
temperature (22 /25 8C) and natural lighting conditions, with free access to water and food
(Nuvital-PR, Brazil). A total of 80 mice were
used. Mercuric chloride and sodium selenite were
dissolved in physiological saline solution to allow
for single intraperitoneal administrations of vo-
181
Protein was measured by the method of Bradford (1976) using bovine serum albumin as the
standard.
3. Results
The renal and hepatic d-ALA-D activities are
reported in Tables 1 and 2, respectively. Hg2,
when administered alone, inhibited renal d-ALAD at 6 and 12 h, but not at 24 and 48 h after
treatment (Table 1), Selenite, when administered
alone, had no effect on renal d-ALA-D at either
timepoint. When both compounds were administered simultaneously, the inhibitory effect of Hg2
was abolished at 12 h after treatment in kidneys.
In liver (Table 2), the enzyme was not inhibited
after acute exposure to Se4 and Hg2. The
182
Table 1
d-ALA-D activity from mouse kidney after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
12 h
8.019/0.12
7.259/0.71
5.819/0.38a,
6.149/0.36a
0.016
24 h
7.959/0.95
7.189/0.39
6.249/0.50a,1,2
7.459/0.25
0.047
48 h
7.999/0.21
8.079/0.20
7.889/0.802,3
7.579/0.24
0.467
8.269/0.29
8.009/0.28
8.369/0.493
7.409/0.58
0.165
0.667
0.171
0.025
0.095
Mice were killed at 6, 12, 24 and 48 h after treatment. Enzyme activity is expressed as nmol of formed porphobilinogen per mg
protein per h. The results are presented as mean9/S.E. (n/5 animals per group). Means not sharing the same superscript letters were
different at the P B/0.05 level (Duncans multiple range test). Comparisons were made within each column (treatment effect). Means
not sharing the same superscript number were different at the P B/0.05 level (Duncans multiple range test). Comparisons were made
within each row (time effect).
4. Discussion
The inhibitory effect of Hg2 on renal d-ALAD after administration of mercury alone was
different from that after simultaneous administration of mercury and selenium at 12 h after
administration (Table 1). In fact, selenite abolished
the inhibitory effect of Hg2 on renal enzyme after
Table 2
d-ALA-D activity from mouse liver after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
23.09/1.66
25.99/1.77
21.99/3.14
20.99/0.65
0.434
12 h
23.09/2.71
25.69/1.08
20.69/1.05
19.99/0.28
0.109
24 h
23.29/0.68
23.09/2.25
22.69/1.78
22.29/0.81
0.951
48 h
23.99/1.32
23.39/0.97
20.79/1.73
20.49/1.91
0.283
Mice were killed at 6, 12, 24 and 48 h after treatment. Enzyme activity is expressed as nmol of formed porphobilinogen per mg
protein per h. The results are presented as mean9/S.E. (n /5 animals per group). Statistical procedures are the same as described in
Table 1.
183
Table 3
NPSH from mouse kidney after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
4.759/0.09
5.099/0.10
3.809/0.44a
3.489/0.44a
0.011
12 h
5.099/0.10
5.129/0.10
2.579/0.15a,1
3.409/0.20b
B/0.001
24 h
48 h
4.459/0.23
4.939/0.21
5.059/0.192
5.159/0.251
0.609
4.629/0.16a
5.199/0.09a,b
5.519/0.20b,2
5.269/0.32a,b,1
0.048
0.301
0.597
B/0.001
0.001
Mice were killed at 6, 12, 24 and 48 h after treatment. NPSH are expressed as nmol/mg protein. The results are presented as mean9/
S.E. (n /5 animals per group). Statistical procedures are the same as described in Table 1.
Table 4
NPSH from mouse liver after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
6.679/0.13
7.209/0.14
5.289/0.70a,1
4.919/0.64a
0.017
12 h
7.359/0.15
7.219/0.15
3.469/0.10a,2
4.759/0.27b
B/0.001
24 h
6.669/0.27
5.879/0.281
4.549/0.39a,1,2
5.339/0.54a,b
0.010
48 h
6.279/0.44
6.379/0.201
5.109/0.631
5.079/0.67
0.173
Mice were killed at 6, 12, 24 and 48 h after treatment. NPSH are expressed as nmol/mg protein. The results are presented as mean9/
S.E. (n /5 animals per group). Statistical procedures are the same as described in Table 1.
184
Table 5
TBARS from mouse kidney after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
12 h
1.799/0.14
1.869/0.15
1.689/0.10
1.859/0.10
0.737
1.559/0.09
1.539/0.12
1.469/0.15
1.739/0.14
0.533
24 h
1.799/0.07
1.699/0.09
1.549/0.15
1.859/0.21
0.444
48 h
1.499/0.07
1.559/0.07
1.619/0.05
2.129/0.16a
0.001
Mice were killed at 6, 12, 24 and 48 h after treatment, TBARS levels are expressed as nmol of MDA per mg protein. The results are
presented as mean9/S.E. (n/5 animals per group). Statistical procedures are the same as described in Table 1.
Table 6
TBARS from mouse liver after acute exposure to mercuric chloride and/or sodium selenite
6h
Control
Na2SeO3
HgCl2
Na2SeO3 plus HgCl2
P value (treatment effect)
2.489/0.18
2.509/0.14
2.459/0.16
2.259/0.05
0.578
12 h
2.179/0.08a
2.229/0.14a
2.719/0.50a,b
3.229/0.64b
0.042
24 h
2.489/0.09
2.539/0.09
2.409/0.12
2.379/0.08
0.601
48 h
2.279/0.06a
2.459/0.10a,b
2.499/0.11a,b
2.639/0.09b
0.089
Mice were killed at 6, 12, 24 and 48 h after treatment. TBARS levels are expressed as nmol of MDA per mg protein. The results are
presented as mean9/S.E. (n/5 animals per group). Statistical procedures are the same as described in Table 1.
185
mercury concentrations in organs were not determined, the absence of Se4-induced NPSH depletion in kidneys (Table 3) can be related to the
lower deposition of Se in kidney when compared
with liver (Hansen and Kristensen, 1979; Gregus et
al., 2001). In line with this, selenite presents a high
affinity by liver (Wilber, 1980).
Selenium inhibited, at least in part, Hg-induced
oxidation of NPSH at 12 h after treatment. This
phenomenon agrees with that observed for dALA-D activity after simultaneous exposure to
Hg2 and Se4. The translocation of Hg2 from
NPSH groups to selenide (generated from selenite)
may contribute to the decreasing oxidation of
renal and hepatic NPSH after 12 h of treatment
in Se /Hg mice.
Lipid peroxidation has been observed after
Hg2 (Fukino et al., 1984; Huang et al., 1996)
and Se4 (Shen et al., 1999; Moak and Christensen, 2001) exposure. However, mercury- and
selenite-induced lipid peroxidation has been described under different conditions of toxicity,
which refer mainly to different doses, different
time of administration and different strain and age
of the animals. Moak and Christensen (2001)
observed increased hepatic lipid peroxidation in
rats fed a diet containing selenite (2.0 mg selenium
per kg diet) only after 15 weeks of treatment.
Fukino et al. (1984) showed increased TBARS
levels in a study where doses and timepoints were
similar to our experimental protocol, however,
they used rats unless mice. Our results did not
show increased TBARS levels in both livers and
kidneys after individual treatment with selenite or
mercuric chloride at either timepoint. The absence
of increased TBARS levels in animals treated with
selenite or mercuric chloride alone is probably
related to the conditions of intoxication, such as
used doses and animal strain.
The reviewed literature indicates that mercuric
ion binds to selenium to form a biologically inert
complex (Hansen, 1988) and the toxicity of the
complex is very low in comparison with mercuric
chloride or sodium selenite. The formation of such
complex of lower toxicity in animals may play an
important role in the modification of toxicity of
mercuric ion by selenite (Naganuma et al., 1982).
In contrast, our results show increasing hepatic
186
and renal TBARS levels in Se /Hg mice, suggesting, in this case, an apparent toxic effect of the
selenium/mercury complex. The increase in hepatic TBARS levels in Se/Hg mice was significant at
12 and 48 h after treatment. The absence of
increased TBARS levels at 24 h after treatment
could be related to the kinetic of formation of Se/
Hg complex and its transport from blood to liver.
The increase in renal TBARS levels was observed
only at 48 h after treatment. This phenomenon is
probably related to the delayed transport of Se/
Hg complex to the kidneys. In fact, the transport
of the Se /Hg complex to the kidney seems to be
limited (Yamamoto, 1985).
In summary, the results of the present study
indicate that Se4 is effective in restoring Hg2inhibited renal d-ALA-D. Moreover, selenite abolished the interaction of Hg2 with sulfhydryl
groups of nonprotein sources. The major shortcoming of therapeutic interventions against Hg2
intoxication resides in the poor ability of monoand dithiol compounds to remove Hg2 from
thiol-containing proteins. Although selenite (Se4)
can present pro-oxidant properties, the effectiveness of Se4 (possibly mediated by selenide) in
reactivating the thiol content of d-ALA-D indicates that selenide should be carefully considered
for the treatment of Hg2 intoxication.
References
Barbosa, N.B.V., Rocha, J.B.T., Zeni, G., Emanuelli, T.,
Beque, M.C., Braga, A.L., 1998. Effect of organic forms
of selenium on d-aminolevulinate dehydratase from liver,
kidney and brain of adult rats. Toxicol. Appl. Pharmacol.
149, 243 /253.
Bradford, M.M., 1976. A rapid and sensitive method for the
quantification of microgram quantities of protein utilizing
the principle of protein /dye binding. Anal. Biochem. 72,
248 /254.
Clarkson, T.W., 2002. The toxicology of mercury. Crit. Rev.
Clin. Lab. Sci. 34, 369 /403.
Cuvin-Aralar, M.L.A., Furness, R.W., 1991. Mercury and
selenium interaction: a review. Ecotoxicol. Environ. Saf.
21, 348 /364.
Ellman, G.L., 1959. Tissue sulphydryl groups. Arch. Biochem.
Biophys. 82, 70 /77.
Farina, M., Folmer, V., Bolzan, R.C., Andrade, L.H., Zeni, G.,
Braga, A.L., Rocha, J.B.T., 2001. Selenoxides inhibit daminolevulinic acid dehydratase. Toxicol. Lett. 119, 27 /37.
187